Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication <it>in vitro </it>and provide a rationale to redesign antiretroviral treatment for feline AIDS
<p>Abstract</p> <p>Background</p> <p>Treatment of feline immunodeficiency virus (FIV) infection has been hampered by the absence of a specific combination antiretroviral treatment (ART). Integrase strand transfer inhibitors (INSTIs) are emerging as a promising new drug...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/4/1/79 |